Genexine
Clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics. Learn more
Launch date
Employees
Market cap
$1.2b
Enterprise valuation
$1.2b (Public information from Aug 2023)
Share price
KRW6290
Seongnam-si Gyeonggi-do (HQ)
Authorizing premium user...